<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>RShiny on Phil Palmer</title><link>https://philpalmer.github.io/blog/tags/rshiny/</link><description>Recent content in RShiny on Phil Palmer</description><generator>Source Themes academia (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Wed, 29 Apr 2020 00:00:00 +0000</lastBuildDate><atom:link href="https://philpalmer.github.io/blog/tags/rshiny/index.xml" rel="self" type="application/rss+xml"/><item><title>DTC support</title><link>https://philpalmer.github.io/blog/project/dtc/</link><pubDate>Wed, 29 Apr 2020 00:00:00 +0000</pubDate><guid>https://philpalmer.github.io/blog/project/dtc/</guid><description>&lt;p>Customer support &amp;amp; bioinformatics pipeline development for Direct To Consumer (DTC) genetics companies such as Sano &amp;amp; Nebula Genomics.&lt;/p>
&lt;p>For example, I developed and improved multiple bioinformatics pipelines based on user feedback including:&lt;/p>
&lt;ul>
&lt;li>&lt;a href="https://blog.lifebit.ai/2019/09/20/achieve-federated-standardised-cloud-native-secondary-genomics-analysis-in-a-heartbeat-with-dragen-deploit/">Dragen&lt;/a>
&lt;ul>
&lt;li>Developed Nextflow pipeline for running Illumina&amp;rsquo;s Dragen pipeline including indexing, mapping, germline/somatic variant calling &amp;amp; copy number variant (CNV) analysis&lt;/li>
&lt;/ul>
&lt;/li>
&lt;li>&lt;a href="https://blog.lifebit.ai/2019/08/29/filling-in-the-blanks-for-direct-to-consumer-genetic-testing-companies-delivering-industrys-fastest-most-scalable-imputation-method/">Imputation&lt;/a>
&lt;ul>
&lt;li>&lt;a href="https://blog.lifebit.ai/2019/05/30/what-is-the-best-imputation-pipeline/">Benchmarked&lt;/a> multiple imputation pipelines&lt;/li>
&lt;li>Greatly improved Lifebit&amp;rsquo;s imputation pipeline by adding &lt;a href="https://github.com/awreynolds/DTC_genomics_convertor/blob/master/validate_23AndMe.R">input validation&lt;/a> &amp;amp; continuous integration testing. This resulted in a highly robust imputation pipeline used in production by direct to consumer genetics companies such as Nebula Genomics and Sano Genetics thousands of times to analyse their customersâ€™ data.&lt;/li>
&lt;li>Built imputation &lt;a href="https://philpalmer.shinyapps.io/lifebit/">RShiny app&lt;/a>&lt;/li>
&lt;/ul>
&lt;/li>
&lt;li>&lt;a href="https://blog.lifebit.ai/2019/10/02/how-growing-consumer-demand-for-ancestry-dna-testing-is-creating-new-challenges-for-dtc-testing-companies/">Ancestry&lt;/a>
&lt;ul>
&lt;li>Developed Lifebit&amp;rsquo;s intial Ancestry pipeline&lt;/li>
&lt;/ul>
&lt;/li>
&lt;/ul></description></item><item><title>Drug repurposing &amp; pathway analysis</title><link>https://philpalmer.github.io/blog/project/drug-repurposing/</link><pubDate>Thu, 09 Apr 2020 00:00:00 +0000</pubDate><guid>https://philpalmer.github.io/blog/project/drug-repurposing/</guid><description>&lt;p>Found drug targets and pathways to accelerate the pharma industry, demoing the results for a pilot with AstraZeneca.&lt;/p>
&lt;p>This was for a project for the &lt;a href="https://lifebit.ai/intelligent-cloud">AI Engine&lt;/a>. I built:&lt;/p>
&lt;ol>
&lt;li>An &lt;a href="https://philpalmer.shinyapps.io/drug_repurposing/">RShiny application&lt;/a> to visaulise the results of the drug targets&lt;/li>
&lt;li>A &lt;a href="https://github.com/lifebit-ai/pathway-analysis">bioinformatics pipeline&lt;/a> in Nextflow to automate the discovery of enriched pathways&lt;/li>
&lt;/ol></description></item><item><title>Antiviral drug repurposing</title><link>https://philpalmer.github.io/blog/project/antiviral-drug-repurposing/</link><pubDate>Sun, 22 Sep 2019 00:00:00 +0000</pubDate><guid>https://philpalmer.github.io/blog/project/antiviral-drug-repurposing/</guid><description>&lt;p>This side project was done for a PhD application research proposal as a proof of concept&lt;/p>
&lt;p>I used differential gene expression analysis &amp;amp; drug repurposing techniques to find compounds with similar gene expression profiles to the HSP90 inhibitor Geldanamycin&lt;/p></description></item></channel></rss>